RxDoctor Payments Data

April Holtry, NP

Primary Care · Chambersburg, PANPI 1801375191

Payments from drug & device makers

$318in general payments, 2019–2025

Across 25 payments — averaging $12.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$148
  • AstraZeneca$50
  • Novo Nordisk$34
  • Astellas Pharma US Inc$20
  • Takeda Pharmaceuticals U.S.A., Inc.$18
  • Dexcom, Inc.$16
  • plus $30 from 2 others

What the payments were for

  • Food & beverage$318100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$318 in reported general payments places this provider in the 45th percentile of 300 primary care providers in Pennsylvania.

See all primary care providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$59,561
Medicare patients
166
Services billed
758

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban73$56,006
OzempicSemaglutide36$39,170
TrulicityDulaglutide16$32,630
MounjaroTirzepatide14$18,137
Tresiba Flextouch U-200Insulin Degludec28$16,442
Tresiba Flextouch U-100Insulin Degludec15$8,961
AbrysvoRsv Vacc, Pref A And Pref B/Pf23$7,334
ShingrixVaricella-Zoster Ge/As01b/Pf15$3,327
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$3,297
Rosuvastatin Calcium93$1,610
Atorvastatin Calcium110$1,533
Levothyroxine Sodium103$1,291
Albuterol Sulfate HfaAlbuterol Sulfate37$1,140
Gabapentin66$942
Diclofenac Sodium52$914

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$148$50,76730 claims
Novo NordiskOzempic$34$39,17036 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 300 primary care providers in Pennsylvania.

Other primary care in Chambersburg

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →